Simplicity Solutions’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-3,010
Closed -$205K 1084
2023
Q3
$205K Buy
3,010
+116
+4% +$9.84K 0.01% 902
2023
Q2
$272K Sell
2,894
-84
-3% -$6.55K 0.01% 867
2023
Q1
$202K Buy
+2,978
New +$191K 0.01% 1014
2022
Q2
Sell
-3,501
Closed -$245K 653
2022
Q1
$245K Sell
3,501
-4,069
-54% -$297K 0.03% 538
2021
Q4
$590K Buy
7,570
+4,164
+122% +$367K 0.07% 339
2021
Q3
$325K Buy
3,406
+1,060
+45% +$112K 0.05% 402
2021
Q2
$292K Buy
2,346
+297
+14% +$35.4K 0.06% 393
2021
Q1
$270K Buy
+2,049
New +$280K 0.06% 383
2019
Q2
Sell
-6,189
Closed -$536K 715
2019
Q1
$536K Buy
+6,189
New +$527K 0.03% 384

Other funds holding EXAS

Simplicity Solutions's EXAS Position: Q4 2023 in Review

Simplicity Solutions sold out of Exact Sciences (EXAS) in Q4 2023, closing a stake of 3,010 shares — an estimated $205K sold.

Simplicity Solutions first reported a position in EXAS in Q1 2019 and held it in 9 quarters. The position peaked at $590K in Q4 2021. 646 funds tracked by Wall St. Rank hold EXAS as of Q4 2023.

  • Simplicity Solutions reported no remaining Exact Sciences position as of Q4 2023 after selling out during the quarter.
  • Simplicity Solutions sold 3,010 Exact Sciences shares in Q4 2023, an estimated $205K.
  • Simplicity Solutions first reported a position in Exact Sciences in Q1 2019 and held it in 9 quarters.
  • Simplicity Solutions's Exact Sciences position peaked at $590K in Q4 2021.
  • 646 funds tracked by Wall St. Rank held Exact Sciences as of Q4 2023.

Based on Simplicity Solutions's 13F filing for Q4 2023, filed 29 Jan 2024.